Bardy Diagnostics Names New CEO

Seattle-based Bardy Diagnostics, a digital health technology and cardiac patch developer, has named Kevin Hykes as its new chief executive officer.

Hykes will take over day-to-day management from the company’s founder and chairman, Gust H. Bardy, who is transitioning into a new role as chief medical officer and chief innovation officer.

Former president and CEO of Relievant Medical Systems, Metavention and Cameron Health, Hykes led the commercialization of Cameron Health’s subcutaneous implantable cardioverter defibrillator.

Bardy Diagnostics’ flagship product, the Carnation Ambulatory Monitor (CAM) cardiac patch, is a bandage-sized patch designed to assist in the diagnosis of arrhythmia.